57 information-security-"https:"-"https:"-"https:" PhD positions at University of Nottingham
Sort by
Refine Your Search
-
, the position is only available for UK home candidates. As sponsored by MTC, the successful candidate would need to pass the sponsors own security checks before starting the PhD. Start date: 5 October 2026
-
year for consumables and travel. Funding from MTC requires passing their security checks before starting the PhD. Vision We are seeking a PhD student that is interested in robotics and automation
-
This exciting opportunity is based within the Power Electronics and Machines Centre (PEMC) Research Group at Faculty of Engineering which conducts cutting edge research into enabling technologies
-
This project is an exciting opportunity to undertake industrially linked research in partnership with the Manufacturing Technology Centre (MTC). It is based within the Advanced Materials Research
-
sponsors own security checks before starting the PhD. Start date: 5 October 2026 Closing date: 27 February 2026 For further information please email Professor Chris Gerada (University of Nottingham) and
-
studentship (UK nationals only) Tax-free stipend: £25,000/year Full home tuition fees paid £2,000/year for consumables and travel MTC funding requires passing security checks prior to starting Project aim
-
Data is more valuable than oil, so it has been said. Quantum computing offers new unusual datasets thereby presenting new opportunities for AI approaches. Quantum computing is raising the prospect
-
Data is more valuable than oil, so it has been said. Quantum computing offers new unusual datasets thereby presenting new opportunities for AI approaches. Quantum computing is raising the prospect
-
of Sport, Exercise, and Nutrition Education – kimberley.edwards@nottingham.ac.uk This project is not funded, and we are seeking a student who can self-fund the PhD. Programme description: Athletes, coaches
-
Glioblastoma (GBM) is the most common and lethal adult brain tumour, with relapse driven by infiltrative tumour cells that escape surgical resection and resist therapy. These residual GBM cells